Drug Database
AM

amphotericin B (Amphomul)

✓ Approved

Bharat Serums and Vaccines Limited · 小分子 · 小分子

什么是 amphotericin B?

amphotericin B 是一种小分子,由Bharat Serums and Vaccines Limited研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)。

药物档案

商品名Amphomul
公司Bharat Serums and Vaccines Limited
药物类别小分子
给药途径Injectable (Others), Intravenous (IV)
状态Approved

治疗适应症

amphotericin B 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsLeishmaniasis✓ Approved
Infections and infestationsWound infection fungal✓ Approved

相关研究文献

PubMedNPJ vaccines2026-11-19

Thrombotic and cerebrovascular events following SARS-CoV-2 vaccination: an umbrella review of systematic reviews and meta-analyses.

Aderinto Nicholas N, Hasan Ahmedyar A, Abioye Aderinola Halimat AH, Mbah Ebube Christopher EC et al.

Rare thrombotic and cerebrovascular events have been reported after SARS-CoV-2 vaccination, raising safety concerns. This umbrella review synthesizes evidence from 19 systematic reviews and meta-analyses examining thrombotic outcomes, including acute ischemic stroke and cerebral venous sinus thrombosis, across different vaccine platforms. Methodological quality was assessed using AMSTAR-2, and findings were synthesized by outcome and platform. Evidence consistently shows that thrombotic and cerebrovascular events following vaccination are rare. mRNA vaccines (BNT162b2, mRNA-1273) were not associated with increased risk beyond background population rates. Adenoviral vector vaccines (ChAdOx1 nCoV-19, Ad26.COV2.S) were linked to a rare syndrome of vaccine-induced immune thrombotic thrombocytopenia, most commonly presenting as cerebral venous sinus thrombosis in younger adults. Evidence for whole-virus vaccines was limited but did not indicate consistent safety concerns. Across all platforms, thrombotic risk was substantially lower than that from SARS-CoV-2 infection. Overall, vaccination benefits outweigh risks, highlighting the importance of ongoing surveillance and transparent communication.

PMID 43052353
阅读全文 →
PubMedBiotechnology letters2026-11-19

Screening of high-strength subgenomic promoters of alphavirus replicase and their co-expression potential in saRNA vaccines.

Zhai Lixin L, Li Liang L, Liu Lei L, Yu Xingao X et al.

Self-amplifying mRNA (saRNA) vaccines represent a promising platform for next-generation vaccines. However, their application is still limited by insufficient antigen expression and the difficulty of achieving precise multi-gene regulation in multivalent vaccine designs. Subgenomic promoters (SGPs) derived from Alphavirus replicase play a critical role in regulating downstream gene transcription and therefore provide an attractive target for promoter engineering. In this study, the 24 nt core sequence of the Alphavirus SGP was targeted for optimization. A randomized mutation library was constructed and screened using a high-throughput fluorescence detection system based on enhanced green fluorescent protein (EGFP) as a reporter. Candidate promoters were subsequently validated through sequencing analysis and cellular expression assays. A total of 20 novel SGP variants with enhanced transcriptional activity were successfully identified. Among them, the 9 G → T mutant showed the most prominent improvement in expression performance. Semi-quantitative fluorescence analysis confirmed that several mutant promoters significantly accelerated the onset of target protein expression and increased overall expression levels compared with the wild-type promoter. RNA secondary structure prediction further suggested that the enhanced promoter activity may be associated with alterations in local stem-loop conformations within the SGP region. In addition, co-transfection assays further demonstrated that the 9 G → T mutant maintains favorable co-expression compatibility with the wild-type SGP, indicating its potential utility in multigene expression systems. These findings provide a set of high-strength subgenomic promoters and an effective screening strategy for saRNA systems, offering practical regulatory elements for improving antigen expression and facilitating the development of multivalent saRNA vaccines.

PMID 43052572
阅读全文 →
PubMedNPJ vaccines2026-11-19

Biosynthesis of a nanoscale Vibrio cholerae conjugate vaccine elicits potent immunity through size and receptor effects.

Wang Kangfeng K, Huang Jing J, Li Juntao J, Li Zhenshi Z et al.

Cholera, caused by Vibrio cholerae, remains a significant global health threat, with the O1 serotype being the predominant cause of recent global outbreaks. Although conjugate vaccines against V. cholerae have been developed via chemical methods, the feasibility of applying novel biosynthetic approaches remains uncertain due to the special structure of its O-polysaccharide, which should be recognized by oligosaccharyltransferases. Here, we successfully established an oligosaccharyltransferase PglL-based glycosylation system in an engineered V. cholerae strain to biosynthesize a nanoscale conjugate vaccine, NP-OPSVc(I). The carrier NP was designed by fusing the cholera toxin B subunit (CTB) with a trimer-forming protein (Tri), which could self‑assemble into a nanoparticle during expression. The resulting glycoprotein exhibited high purity, stability, and retained GM1-binding capacity. We found that the size of NP-OPSVc(I) and its GM1 receptor targeting both contribute to a potent humoral immune response, while its efficient delivery is additionally associated with the induction of intestinal mucosal immunity. In mouse models, the NP-OPSVc(I) demonstrated a favorable safety profile and elicited substantially stronger systemic and mucosal immune responses than conventional conjugates, providing great protection against lethal V. cholerae challenge even at a 10‑fold lower dose without requiring an adjuvant. Furthermore, the immune responses were confirmed in non-human primates, supporting its potential for clinical translation. This work not only developed a novel highly effective candidate vaccine against V. cholerae but also significantly expanded the application scope of the PglL-based platform technology, establishing it as a versatile and broadly applicable enzymatic toolkit for vaccine development.

PMID 43052362
阅读全文 →
PubMedExperimental hematology & oncology2026-11-19

A targetable SWI/SNF dependency sustains survival in pediatric B-ALL.

Montenegro-Elvira Fernando F, Castro-Gonzalez Sergio S, De Los Santos-Jiménez Juan J, Medina Pedro P PP

Pediatric B-cell acute lymphoblastic leukemia (B-ALL) remains a major clinical challenge driven by molecular heterogeneity and therapeutic resistance. While the SWI/SNF chromatin-remodeling complex is a recognized dependency in myeloid and T-cell leukemias, its role in B-ALL remains poorly defined. Here, we identify a conserved requirement for the SWI/SNF ATPases SMARCA4 and SMARCA2 across diverse B-ALL genetic subtypes. SMARCA4 expression correlates with inferior overall survival in the pediatric B-ALL TARGET cohort. Using a panel of B-ALL models representing ETV6-RUNX1, BCR-ABL1, and KMT2A-rearranged subtypes, we show that dual SMARCA2/4 inhibition, using the ATPase inhibitor BRM014 or the PROTAC degrader ACBI1, induces profound loss of viability. This vulnerability is characterized by G0/G1 cell cycle arrest and a robust apoptotic response. Mechanistically, comparative RNA sequencing identified a high-confidence 26-gene "identity core" consistently downregulated upon SWI/SNF disruption with BRM014. This program integrates lymphocyte activation, cytokine signaling, and trafficking modules, including the key niche-interaction receptor CXCR4, and is accompanied by depletion of MYC and E2F transcriptional programs. Finally, BRM014 demonstrated significant growth-inhibitory activity in vivo in an REH xenograft model, with a significant delay in disease progression during the observation window. These findings establish the SWI/SNF complex as a conserved survival dependency in the tested B-ALL models and provide a rationale for targeting SMARCA2/4 to inhibit intrinsic growth in B-ALL.

PMID 43053129
阅读全文 →
PubMedParasites & vectors2026-11-19

Probiotic potential of Blautia producta L1 in mitigating Eimeria tenella-induced intestinal inflammation and dysbiosis in chickens.

Liu Jianhua J, Yuan Cheng C, Zhang Guangji G, Zhao Changjing C et al.

The capacity of Blautia to restore microbial homeostasis and attenuate intestinal inflammation highlights its potential as a promising microbial therapeutic for poultry coccidiosis. A total of 75 one-day-old male Hy-Line layer chicks were randomly allocated into five groups (n=15 per group): mock control, challenged control, B. producta L1 control, B. producta L1-challenged, and inactivated B. producta L1-challenged. From day 1 to day 22, chickens in the B. producta L1-treatment groups were orally administered either live or heat-inactivated B. producta L1 at 2 × 10⁸ CFU/mL (1 mL/bird) once daily. On day 14, chickens in the challenged groups were orally gavaged with 3 × 104 sporulated E. tenella oocysts. Protective efficacy was assessed by body weight gain, fecal oocyst out, cecal lesion score (0-4), and histopathological examination of intestinal epithelium. The anticoccidial index (ACI) was also calculated. Inflammatory cytokines including IL-1β, IL-6, TNF-α, and IL-10 were analyzed by ELISA, and mRNA expression of genes related to cecal inflammatory pathways was analyzed by qRT-PCR. The composition of the cecal microbiota was profiled using 16S rRNA gene sequencing. Supplementation with either live or heat-inactivated B. producta L1 conferred measurable protection against E. tenella challenge. Body weight gain in the live and inactivated B. producta L1-treated groups was significantly greater than that of the challenged control group (p < 0.01). Cecal lesion scores and fecal oocyst output were markedly reduced in both B. producta L1-treated groups compared with the challenged control group (p < 0.001 for both). Survival was 100% in both B. producta L1-treated groups and 86.7% (13/15) in the challenged control group. However, the between-group difference in survival was not statistically significant. The ACI values of the live and inactivated B. producta L1-treated groups were 162.0 and 151.6, respectively, corresponding to medium-effective and effective protection according to the established ACI criteria, compared with 102.2 in the challenged control group. Histopathological examination showed less epithelial degeneration, necrosis, and villus atrophy in B. producta L1-treated birds. Moreover, B. producta L1 supplementation significantly decreased serum concentrations of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α; p < 0.01) and increased the anti-inflammatory cytokine IL-10 (p < 0.05), while downregulating mRNA expression of TLR4, MYD88, NF-κB, NLRP3, P65, and Caspase-3 in cecal tissues (p < 0.05 for all). 16S rRNA gene sequencing further demonstrated that B. producta L1 increased cecal microbial richness and diversity, with higher relative abundances of beneficial genera such as Blautia and Lactobacillus and lower abundances of potentially pathogenic taxa including Salmonella, Acinetobacter, and Erysipelatoclostridium (p < 0.05). B. producta L1 moderately ameliorates E. tenella-induced pathology by helping preserve intestinal barrier integrity, dampening inflammatory responses, and reshaping the gut microbial ecosystem. These findings support B. producta L1 as a promising probiotic or postbiotic candidate for complementary control of E. tenella infection in poultry, although further benchmarking against standard anticoccidial agents and identification of active bioactive components are required.

PMID 43053077
阅读全文 →
PubMedJournal of applied toxicology : JAT2026-11-19

Exploratory Assessment of Biochemical and Behavioral Profiles in a Tropical Freshwater Fish (Astyanax sp.) Exposed to Fire-Derived Microplastics.

Estrada Teresa de Jesús Monserrat López TJML, Mejía Nancy Priscila Ayala NPA, Sierra Ana Marlen Acosta AMA, Acevedo Nayeli Leticia Cortés NLC et al.

Incomplete combustion of plastic waste is an emerging pathway for forming thermally transformed microplastics (MPs), whose physicochemical identity and ecotoxicological potential in aquatic vertebrates remain poorly understood, as available evidence has focused primarily on the toxicity of their leachates and extracts. Accordingly, we conducted an exploratory investigation of biochemical and behavioral profiles in juvenile Astyanax sp. exposed to MPs derived from the burning of expanded polystyrene (B-EPSMPs) and polyethylene terephthalate (B-PETMPs), integrating physicochemical characterization, behavioral responses, and biochemical biomarkers. Fish were allocated to Control, B-EPSMP, and B-PETMP groups, with 20 individuals maintained in one exposure aquarium per group for 10 days at a nominal B-MP concentration of 4 mg/L. Although the materials exhibited high morphometric similarity, Raman and UV-Vis analyses revealed distinct structural and spectroscopic profiles in the combustion-derived materials. No mortality was observed, but the exposed groups exhibited distinct sublethal response profiles. In the gastrointestinal tract, fish from both B-MP groups showed higher ROS and MDA levels and higher CAT and MPO-like activities relative to the Control group. Encephalic biochemical differences were more pronounced in the B-EPSMP group, including higher nitrite and dopamine levels, enhanced AChE activity, and lower BChE activity. Basal locomotor behavior remained largely preserved, whereas behavioral paradigms involving novelty and social interaction revealed differences among the observed groups. Fish from the B-EPSMP group exhibited greater locomotor reactivity to novelty and reduced interspecific social responsiveness toward Hyphessobrycon eques, whereas fish from the B-PETMP group mainly showed differences in novel-object exploration. Multiblock integration identified distinct biochemical-behavioral patterns among the sampled groups, with greater separation associated with the B-EPSMP group. Because each treatment was represented by a single exposure aquarium, these findings describe exploratory, tank-confounded associations rather than independently replicated treatment effects. Overall, the study provides preliminary evidence of distinct biological response patterns in fish exposed to fire-derived MPs and establishes a basis for future investigations using independently replicated exposure units.

PMID 43053470
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多amphotericin B